Acuitas Investments LLC Sells 217,141 Shares of KORU Medical Systems, Inc. $KRMD

Acuitas Investments LLC decreased its holdings in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) by 53.9% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 185,353 shares of the company’s stock after selling 217,141 shares during the period. Acuitas Investments LLC’s holdings in KORU Medical Systems were worth $710,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Police & Firemen s Retirement System of New Jersey purchased a new position in KORU Medical Systems in the second quarter valued at about $30,000. Lazard Asset Management LLC bought a new stake in shares of KORU Medical Systems during the 2nd quarter valued at about $59,000. Acadian Asset Management LLC purchased a new stake in shares of KORU Medical Systems during the 1st quarter valued at $63,000. Intech Investment Management LLC bought a new position in shares of KORU Medical Systems during the 2nd quarter valued at about $73,000. Finally, Invesco Ltd. purchased a new position in shares of KORU Medical Systems during the second quarter worth approximately $80,000. 58.60% of the stock is owned by institutional investors.

KORU Medical Systems Stock Performance

KRMD stock opened at $5.45 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.48 and a quick ratio of 1.92. The company has a market capitalization of $252.44 million, a P/E ratio of -68.13 and a beta of 0.51. The business has a 50-day moving average price of $5.72 and a 200 day moving average price of $4.56. KORU Medical Systems, Inc. has a 1-year low of $1.86 and a 1-year high of $6.61.

Analysts Set New Price Targets

KRMD has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of KORU Medical Systems from a “buy” rating to a “strong-buy” rating in a report on Monday, January 12th. Weiss Ratings restated a “sell (d-)” rating on shares of KORU Medical Systems in a report on Thursday, January 22nd. Canaccord Genuity Group lifted their target price on KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. Craig Hallum restated a “buy” rating and issued a $7.00 target price on shares of KORU Medical Systems in a report on Tuesday, January 13th. Finally, Lake Street Capital boosted their target price on shares of KORU Medical Systems from $6.00 to $8.00 and gave the company a “buy” rating in a research report on Monday, December 22nd. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, KORU Medical Systems has an average rating of “Moderate Buy” and a consensus target price of $6.13.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.